Discontinuing Anticoagulation After Ablation and Cognitive Health: Is Memory Truly at Risk?

Key Takeaway

In patients remaining free of atrial fibrillation recurrences for one year following catheter ablation, discontinuing oral anticoagulation was not associated with accelerated cognitive decline over a two-year period. Both cohorts demonstrated virtually identical scores on cognitive assessments. While reassuring, these preliminary findings should inform nuanced shared decision-making between clinician and patient rather than definitively close the book on the anticoagulation debate.

The Patient Asking to Stop Blood Thinners

Consider a 64-year-old retired engineer, now 18 months out from pulmonary vein isolation. His serial Holter monitoring throughout this period has been entirely unremarkable. Although the palpitations in his chest have long resolved, he continues to take his daily anticoagulant. The easy bruising on his forearms from weekend gardening and a lingering sense of apprehension whenever he climbs a ladder, however, persist. “If my rhythm is back to normal,” he asks, “why am I still taking this medication?” His physician hesitates—and stroke risk is not the only source of caution. Even in patients who have never suffered an overt clinical stroke, atrial fibrillation increases…